The biologic basis of clinical heterogeneity in juvenile idiopathic arthritis

Arthritis and Rheumatology

Volumn 66, Issue 12, 2014, Pages 3463-3475

  Eng, Simon W M ^a   Duong, Trang T ^a   Rosenberg, Alan M ^b   Morris, Quaid ^c   Yeung, Rae S M ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; HEMOGLOBIN; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; INTERLEUKIN 6; AUTACOID; CYTOKINE;

ARTICLE; COHORT ANALYSIS; CONCEPTUAL FRAMEWORK; DATA PROCESSING; DISEASE ACTIVITY; DISEASE CLASSIFICATION; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MACHINE LEARNING; MAJOR CLINICAL STUDY; ONSET AGE; PATIENT CODING; PRINCIPAL COMPONENT ANALYSIS; PSORIATIC ARTHRITIS; SENSITIVITY ANALYSIS; THROMBOCYTE COUNT; VALIDATION STUDY; ADOLESCENT; AGE; ARTHRITIS, JUVENILE; CHILD; CLASSIFICATION; CLUSTER ANALYSIS; DELAYED DIAGNOSIS; FEMALE; IMMUNOLOGY; INFANT; MALE; PRESCHOOL CHILD; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; STATISTICAL ANALYSIS;

ADOLESCENT; AGE FACTORS; ARTHRITIS, JUVENILE; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; COHORT STUDIES; CYTOKINES; DATA INTERPRETATION, STATISTICAL; DELAYED DIAGNOSIS; FEMALE; HUMANS; INFANT; INFLAMMATION MEDIATORS; MALE; PRINCIPAL COMPONENT ANALYSIS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 84912016927     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38875     Document Type: Article

References (52)

1. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 390-2.
2. Martini A,. It is time to rethink juvenile idiopathic arthritis classification and nomenclature. Ann Rheum Dis 2012; 71: 1437-9.
3. Hunter PJ, Wedderburn LR,. Pediatric rheumatic disease: can molecular profiling predict the future in JIA? Nat Rev Rheumatol 2009; 5: 593-94.
4. Hinks A, Cobb J, Sudman M, Eyre S, Martin P, Flynn E, et al. Investigation of rheumatoid arthritis susceptibility loci in juvenile idiopathic arthritis confirms high degree of overlap. Ann Rheum Dis 2012; 71: 1117-21.
5. Hinks A, Eyre S, Ke X, Barton A, Martin P, Flynn E, et al. Association of the AFF3 gene and IL2/IL21 gene region with juvenile idiopathic arthritis. Genes Immun 2010; 11: 194-8.
6. Hinks A, Martin P, Flynn E, Eyre S, Packham J, Childhood Arthritis Prospective Study (CAPS), UKRAG Consortium, BSPAR Study Group, et al. Association of the CCR5 gene with juvenile idiopathic arthritis. Genes Immun 2010; 11: 584-9.
7. Omoyinmi E, Forabosco P, Hamaoui R, Bryant A, Hinks A, Ursu S, et al. Association of the IL-10 gene family locus on chromosome 1 with juvenile idiopathic arthritis (JIA). PLoS One 2012; 7: e47673.
8. Ogilvie EM, Khan A, Hubank M, Kellam P, Woo P,. Specific gene expression profiles in systemic juvenile idiopathic arthritis. Arthritis Rheum 2007; 56: 1954-65.
9. Jarvis JN, Jiang K, Frank MB, Knowlton N, Aggarwal A, Wallace CA, et al. Gene expression profiling in neutrophils from children with polyarticular juvenile idiopathic arthritis. Arthritis Rheum 2009; 60: 1488-95.
10. Barnes MG, Aronow BJ, Luyrink LK, Moroldo MB, Pavlidis P, Passo MH, et al. Gene expression in juvenile arthritis and spondyloarthropathy: pro-angiogenic ELR+ chemokine genes relate to course of arthritis. Rheumatology (Oxford) 2004; 43: 973-9.
11. Barnes MG, Grom AA, Thompson SD, Griffin TA, Pavlidis P, Itert L, et al. Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis. Arthritis Rheum 2009; 60: 2102-12.
12. Allantaz F, Chaussabel D, Stichweh D, Bennett L, Allman W, Mejias A, et al. Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade. J Exp Med 2007; 204: 2131-44.
13. Griffin TA, Barnes MG, Ilowite NT, Olson JC, Sherry DD, Gottlieb BS, et al. Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets. Arthritis Rheum 2009; 60: 2113-23.
14. Rooney M, Varsani H, Martin K, Lombard PR, Dayer JM, Woo P,. Tumour necrosis factor α and its soluble receptors in juvenile chronic arthritis. Rheumatology (Oxford) 2000; 39: 432-8.
15. Shahin AA, Shaker OG, Kamal N, Hafez HA, Gaber W, Shahin HA,. Circulating interleukin-6, soluble interleukin-2 receptors, tumor necrosis factor α, and interleukin-10 levels in juvenile chronic arthritis: correlations with soft tissue vascularity assessed by power Doppler sonography. Rheumatol Int 2002; 22: 84-8.
16. Lotito AP, Campa A, Silva CA, Kiss MH, Mello SB,. Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis. J Rheumatol 2007; 34: 823-30.
17. Cattalini M, Maduskuie V, Fawcett PT, Brescia AM, Rose CD,. Predicting duration of beneficial effect of joint injection among children with chronic arthritis by measuring biomarkers concentration in synovial fluid at the time of injection. Clin Exp Rheumatol 2008; 26: 1153-60.
18. Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J,. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 2005; 201: 1479-86.
19. Scola MP, Thompson SD, Brunner HI, Tsoras MK, Witte D, Van Dijk MA, et al. Interferon-γ:interleukin 4 ratios and associated type 1 cytokine expression in juvenile rheumatoid arthritis synovial tissue. J Rheumatol 2002; 29: 369-78.
20. De Jager W, Hoppenreijs EP, Wulffraat NM, Wedderburn LR, Kuis W, Prakken BJ,. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Ann Rheum Dis 2007; 66: 589-98.
21. Van den Ham HJ, de Jager W, Bijlsma JW, Prakken BJ, de Boer RJ,. Differential cytokine profiles in juvenile idiopathic arthritis subtypes revealed by cluster analysis. Rheumatology (Oxford) 2009; 48: 899-905.
22. Hunter PJ, Nistala K, Jina N, Eddaoudi A, Thomson W, Hubank M, et al. Biologic predictors of extension of oligoarticular juvenile idiopathic arthritis as determined from synovial fluid cellular composition and gene expression. Arthritis Rheum 2010; 62: 896-907.
23. Angeles-Han S, Prahalad S,. The genetics of juvenile idiopathic arthritis: what is new in 2010? Curr Rheumatol Rep 2010; 12: 87-93.
24. Thompson SD, Marion MC, Sudman M, Ryan M, Tsoras M, Howard TD, et al. Genome-wide association analysis of juvenile idiopathic arthritis identifies a new susceptibility locus at chromosomal region 3q13. Arthritis Rheum 2012; 64: 2781-91.
25. Prakken B, Albani S, Martini A,. Juvenile idiopathic arthritis. Lancet 2011; 377: 2138-49.
26. Committee on a Framework for Developing a New Taxonomy of Disease, National Academy of Sciences. Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease (2011). Washington (DC): National Academies Press; 2011. URL: http://dels.nas.edu/report/toward-precision-medicine-building-knowledge/13284.
27. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A,. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997; 40: 1202-9.
28. Stacklies W, Redestig H, Scholz M, Walther D, Selbig J,. pcaMethods: a Bioconductor package providing PCA methods for incomplete data. Bioinformatics 2007; 23: 1164-7.
29. Nyamundanda G, Brennan L, Gormley IC,. Probabilistic principal component analysis for metabolomic data. BMC Bioinformatics 2010; 11: 571.
30. Fraley C, Raftery AE,. MCLUST version 3 for R: normal mixture modeling and model-based clustering. Seattle: University of Washington; 2006.
31. Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D, et al. Circos: an information aesthetic for comparative genomics. Genome Res 2009; 19: 1639-45.
32. Singh G, Athreya BH, Fries JF, Goldsmith DP,. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 1994; 37: 1761-9.
33. Duffy CM, Arsenault L, Duffy KN, Paquin JD, Strawczynski H,. The Juvenile Arthritis Quality of Life Questionnaire-development of a new responsive index for juvenile rheumatoid arthritis and juvenile spondyloarthritides. J Rheumatol 1997; 24: 738-46.
34. Novembre J, Johnson T, Bryc K, Kutalik Z, Boyko AR, Auton A, et al. Genes mirror geography within Europe [published erratum appears in Nature 2008;456:274]. Nature 2008; 456: 98-101.
35. Markle JG, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 2013; 339: 1084-8.
36. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al. A core gut microbiome in obese and lean twins. Nature 2009; 457: 480-4.
37. Ravelli A, Varnier GC, Oliveira S, Castell E, Arguedas O, Magnani A, et al. Antinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis. Arthritis Rheum 2011; 63: 267-75.
38. Barnes MG, Grom AA, Thompson SD, Griffin TA, Luyrink LK, Colbert RA, et al. Biologic similarities based on age at onset in oligoarticular and polyarticular subtypes of juvenile idiopathic arthritis. Arthritis Rheum 2010; 62: 3249-58.
39. Cosmi L, Cimaz R, Maggi L, Santarlasci V, Capone M, Borriello F, et al. Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis. Arthritis Rheum 2011; 63: 2504-15.
40. Ravelli A, Grom AA, Behrens EM, Cron RQ,. Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment. Genes Immun 2012; 12: 289-98.
41. Ravelli A, Felici E, Magni-Manzoni S, Pistorio A, Novarini C, Bozzola E, et al. Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease. Arthritis Rheum 2005; 52: 826-32.
42. Brunner HI, Klein-Gitelman MS, Miller MJ, Trombley M, Baldwin N, Kress A, et al. Health of children with chronic arthritis: relationship of different measures and the quality of parent proxy reporting. Arthritis Rheum 2004; 51: 763-73.
43. Falcone A, Cassone R, Rossi E, Pistorio A, Martini A, Ravelli A,. Inter-observer agreement of the physician's global assessment of disease activity in children with juvenile idiopathic arthritis. Clin Exp Rheumatol 2005; 23: 113-6.
44. Gattorno M, Chicha L, Gregorio A, Ferlito F, Rossi F, Jarrossay D, et al. Distinct expression pattern of IFN-α and TNF-α in juvenile idiopathic arthritis synovial tissue. Rheumatology (Oxford) 2007; 46: 657-65.
45. De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, et al. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med 2012; 367: 2385-95.
46. Pignatti P, Vivarelli M, Meazza C, Rizzolo MG, Martini A, De Benedetti F,. Abnormal regulation of interleukin 6 in systemic juvenile idiopathic arthritis. J Rheumatol 2001; 28: 1670-6.
47. De Benedetti F, Massa M, Robbioni P, Ravelli A, Burgio GR, Martini A,. Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum 1991; 34: 1158-63.
48. Ilowite N, Porras O, Reiff A, Rudge S, Punaro M, Martin A, et al. Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study. Clin Rheumatol 2009; 28: 129-37.
49. Ungar WJ, Costa V, Burnett HF, Feldman BM, Laxer RM,. The use of biologic response modifiers in polyarticular-course juvenile idiopathic arthritis: a systematic review. Semin Arthritis Rheum 2013; 42: 597-618.
50. Suppiah V, Rooney M, Vandenbroeck K,. Polymorphisms in the interleukin-4 and IL-4 receptor genes modify risk for chronic inflammatory arthropathies in women. Exp Mol Pathol 2006; 81: 239-44.
51. + T cells in juvenile rheumatoid arthritis synovial fluid defines a subset of cells with increased IL-4:IFN-γ mRNA ratios. J Immunol 2001; 166: 6899-906.
52. Matheson LA, Duong TT, Rosenberg AM, Yeung RS,. Assessment of sample collection and storage methods for multicenter immunologic research in children. J Immunol Methods 2008; 339: 82-9.